Integer (NYSE:ITGR) vs. Adagio Medical (NASDAQ:ADGM) Head-To-Head Comparison

Integer (NYSE:ITGR) and Adagio Medical (NASDAQ:ADGM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Integer and Adagio Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Adagio Medical	N/A	-312.04%	-66.00%

Valuation & Earnings

This table compares Integer and Adagio Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85 billion	1.62	$102.81 million	$4.01	21.98
Adagio Medical	$600,000.00	36.09	-$25.08 million	($1.73)	-0.56

Integer has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Integer and Adagio Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0	6	4	0	2.40
Adagio Medical	1	1	2	0	2.25

Integer presently has a consensus price target of $98.29, indicating a potential upside of 11.49%. Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 258.97%. Given Adagio Medical’s higher probable upside, analysts clearly believe Adagio Medical is more favorable than Integer.

Volatility and Risk

Integer has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of -0.14, suggesting that its stock price is 114% less volatile than the S&P 500.

Insider and Institutional Ownership

99.3% of Integer shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 5.2% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Integer beats Adagio Medical on 11 of the 14 factors compared between the two stocks.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.